Abstract: A tissue engineering approach using human mesenchymal stem cells (MSCs) can be used to regenerate bone/ cartilage tissue. For effective tissue regeneration, cell cultivation under biologically safe conditions is essential. The objective of this study was to determine suitable antibiotic concentrations in culture media for MSCs while maintaining their inherent capabilities for proliferation and osteogenic/chondrogenic differentiation. When human MSCs were cultured with over 200 µg/mL of gentamicin, the rate of cell growth decreased significantly. In contrast, a concentration of 20 µg/mL gentamicin supported cell proliferation and differentiation capability very well and did not change the expression patterns of cell surface antigens (CD44+, CD105+, CD34-, CD45-). The concentration of 20 µg/ml is much higher than that of the MIC (Minimum Inhibition Concentration) of common bacteria, such as Staphylococcus aureus, Haemophilus influenzae and Escherichia coli. Therefore, we recommend 20 µg/mL of gentamicin in culture media for effective tissue regeneration to avoid bacterial contamination and maintain the osteogenic/chondrogenic capability of MSCs. (J Toxicol Pathol 2008; 21: 61-67) 
Introduction
Mesenchymal stem cells (MSCs) isolated from bone marrow are multipotent cells and can differentiate both in vitro and in vivo into a variety of mesenchymal tissues, such as bone, cartilage, tendon or fat 1 . In vitro cultured MSCs have already been applied clinically for bone or cartilage regeneration [2] [3] [4] . Several antibiotics are commonly used during cell cultivation to prevent bacterial contamination. These antibiotics include penicillin G, streptomycin, kanamycin and gentamicin. However, some antibiotics have been reported to have detrimental effects at high concentrations, such as decreasing cell replication or causing cell death, on in vivo and in vitro osteogenic conditions including human osteoblastic cell culture [5] [6] [7] [8] [9] . Administration of penicillin G to patients is known to bind serum protein. This complex is recognized to be an antigen that may cause an anaphylactic reaction. Aminoglycoside antibiotics, such as streptomycin, kanamycin and gentamicin, are generally known to have a wide spectrum of antibacterial activity compared with those of β-lactam antibiotics, such as penicillin G. In regard to the optimum concentration of antibiotics for prevention of bacterial growth, gentamicin is more effective than kanamycin because it has a low MIC (Minimum Inhibition Concentration) compared with that of kanamycin. Due to its excellent antibacterial activity, gentamicin is the ideal a n t i b i o t i c c a n d i d a t e f o r p r e v e n t i o n o f b a c t e r i a l contamination in MSC cultures. Others have also used it in various cell culture conditions [10] [11] [12] [13] . However, its optimum concentration in a culture medium to support MSC proliferation/differentiation and concomitant bacterial growth inhibition has not been well described.
The objective of this study was to determine the appropriate concentration of gentamicin for maintenance of human MSC proliferation followed by osteo-chondrogenic differentiation. This information will enable us to use MSCs having differentiation capability in the field of regenerative medicine with a minimum fear of bacterial contamination.
Materials and Methods
A schematic diagram of each section that follows is shown in Fig. 1 .
Ethics
These experiments were conducted in accordance with the local ethics committees of both the National Institute of Advanced Industrial Science and Technology (AIST) and Nara Medical University.
Preparation of MSCs from human bone marrow
Adult human bone marrow cells were collected from the anterior iliac crests of two donors (62 years old, male, Osteoarthritis; 67 years old, female, Osteoarthritis) with informed consent. The cells from both donors were used for further study. Each study was performed in triplicate. Adult human bone marrow cells were isolated as described previously 1 . We aspirated 3 ml of fresh bone marrow cells and placed them in a tube containing 3 ml of 10 U/ml heparinized phosphate buffered saline (PBS, Invitrogen Corporation, CA, USA). The tube was centrifuged at 140 g for 10 min at 4°C, and the plasma supernatant with the fat layer was discarded. The residue (buffy coat and red blood cells) was equally divided into two T-75 flasks (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) with 15 ml of Eagles minimum essential medium alpha (α-MEM, Invitrogen Corporation) and 15% of fetal bovine serum (FBS, JRH Biosciences Inc, KS, USA) and then cultured in a humidified atmosphere of 95% air with 5% CO 2 at 37°C. After three days of culture, the non-adherent cells were removed and 13 ml of the culture medium was added. The medium was changed 3 times per week.
After about eleven days of primary cultivation, adherent cells grew well and became subconfluent. The primary cultured adherent cells were fibroblastic in shape with surface markers of the mesenchymal cell type. The cells exhibited good proliferation and capability for osteochondrogenic differentiation, as described later. Therefore, in this paper, we designate these cells as mesenchymal stem cells (MSCs). The effect of gentamicin on MSC proliferation and cell surface antigen expression and differentiation was studied after release from the primary culture flasks using 0.05% trypsin/0.53 mM EDTA (Invitrogen Corporation).
Effect of gentamicin on MSC proliferation
The trypsinized MSCs were collected and centrifuged at 720 g for 10 minutes at 4°C. Subsequently, 1 × 10 5 cells were seeded into a T75 flask in 13 ml of the abovementioned medium containing 0-500 µg/ml of gentamicin (Schering-Plough, Kenilworth, NJ, USA).
The medium was replaced after 24 hours with the same media containing various concentrations of gentamicin. After 4 days of culture, the cells were harvested and the number of cells was counted using NucleoCounter (ChemoMetec, Allerod, Denmark).
Effect of gentamicin on cell surface antigen expression of MSCs
After 4 days of culture with 20 µg/ml of gentamicin as described above, the cells were harvested into 1. 
Effect of gentamicin on osteogenic differentiation
The trypsinized MSCs were seeded at a cell density of 1 × 10 4 cells/cm 2 onto a 12-well culture plate and cultured in a medium supplemented with 10 mM β-glycerophosphate concentrations of gentamicin (0-200 µg/ml) for two or three weeks. The cells were also cultured without dexamethasone as a negative control because dexamethasone is well known as an osteogenic inducer for MSC culture 1 . To quantify formation of the mineralized extracellular matrix, 1 µg/ml of calcein (Dojindo Laboratories, Kumamoto, Japan) was added during the culture period 14 . The fluorescence intensities of calcein correspond well with the contents of calcium in the mineralized matrix 15 . After 14 days of culture, the cell layers were washed twice with PBS, and the fluorescence intensity of the deposited calcein was quantified using an image analyzer (Typhoon 8600, Molecular Dynamics Inc., Sunnyvale, CA, USA) 15 .
Effect of gentamicin on chondrogenic differentiation
A system of pellet culture 16 was adapted with minor modification for chondrogenic differentiation. About 200,000 trypsinized MSCs in a 15-ml polypropylene tube were centrifuged. The resulting pellets were cultured in chondrogenic media consisting of high-glucose DMEM supplemented with 10 ng/ml TGF-β3 (R&D Systems, Minneapolis, MN, USA) and 10 -7 M dexamethasone, 50 µg/ ml ascorbate 2-phosphate, 40 µg/ml prolin, 100 µg/ml pyruvate and 50 mg/ml ITS Premix (Becton Dickinson and Company; 6.25 µg/ml insulin, 6.25 µg/ml transferrin, 6.25 ng/ml selenious acid, 1.25 mg/ml bovine serum albumin and 5.35 mg/ml linoleic acid)16.
We also added 20 µg/ml of gentamicin to the chondrogenic medium and replaced the medium every 2 to 3 days per week for 21 days. The pellets were embedded in paraffin, cut into 5-µm sections and stained with toluidine blue.
Results
MSCs were cultured for 4 days in the presence or absence of gentamicin, and the total cell number was calculated. The growth rate of MSCs with gentamicin at a concentration of less than 100 µg/ml was comparable to that of MSCs without gentamicin. However, the rate of cell growth decreased significantly in the presence of 200 µg/ml or 500 µg/ml of gentamicin (Fig. 2) . Cell morphology was similar in the presence of gentamicin at various concentrations, although the number of cells cultured in the presence of 200 µg/ml was rather sparse compared with the low gentamicin concentration (Fig. 3) .
The medium containing β-glycerophosphate, Lascorbic acid phosphate and importantly dexamethasone can induce MSCs into osteoblasts resulting in the formation of a mineralized matrix. As we previously reported 4 , mineralization (bone matrix formation) could be detected after about 10 or 14 days of MSC culture and could be much more easily detected after 21 days. As shown in Fig. 4 , the MSCs cultured with dexamethasone for 14 days exhibited mineralization (black areas indicated by arrows). The mineralization was also confirmed by detection of high calcein uptake using an image analyzer (Fig. 5) . The amount of mineralization found by microscopy and by the image analyzer did not change when the culture was performed in the presence of gentamicin at a concentration of 10 or 20 µg/ ml. However, the amount decreased when the culture was performed in the presence of higher concentrations of gentamicin (Figs. 4 and 5) . Therefore, at a concentration of 20 µg/ml, gentamicin did not affect osteoblastic differentiation of the MSCs. As described above, this concentration well supported MSC growth. Based on these results, a concentration of 20 µg/ml was adopted for the following studies involving cell surface and chondrogenic differentiation analysis.
MSCs cultured for 4 days in the presence (20 µg/ml) or absence of gentamicin were analyzed using a flow cytometer to determine the expression of surface antigens CD34, CD44, CD45 and CD105 (Fig. 6 ). Both sets of MSCs exhibited negative expression for the hematopoietic cell markers CD34 and CD45, but strong positive expression for the hyaluronic acid receptor marker of CD44 and TGF β1/3
receptor marker of CD105. The patterns of the cell surface antigen expressions were quite similar in both MSC preparations, indicating that gentamicin at a concentration of 20 µg/ml did not affect the antigen expression of MSCs and that the cells were mesenchymal types.
The effect of gentamicin on the chondrogenesis of MSCs was also examined. As reported previously 17 , when human MSCs were cultured as pellets for 3 weeks in a defined medium containing TGF β3 and dexamethasone, the size of the cell pellets increased. There was no difference in size between MSCs cultured with or without gentamicin. In T h e c u l t u r e w a s i n t h e p r e s e n c e o f dexamethasone for 14 days. Culture without dexamethasone (without Dex) was also performed as a negative control. The data represents the mean ± SD (standard deviation) of 3 samples.
addition, both types of MSC pellets were similarly stained by toluidine blue, which indicates proteoglycan synthesis in the chondrocyte matrix (Fig. 7) . This result confirmed that 20 µg/ml of gentamicin did not affect chondrogenic differentiation of the MSCs.
Discussion
Human MSCs can differentiate into either osteogenic or chondrogenic lineage. Thus, MSCs are useful cell sources for tissue engineering with the goal of hard tissue repair 1 . In this regard, an important issue is the prevention of disease transmission. In particular, bacterial contamination should be avoided during culture of MSCs. Because living cells cannot be sterilized without damaging the cells, sterilization protocols cannot be applied for preventing disease transmission. Therefore, antibacterial drugs (antibiotics) should be used for this purpose. However, the types of antibiotics and their effective concentrations for culture of human MSCs have not been well documented. Gentamicin has a low bacteria MIC and exhibits a wide spectrum of antibacterial activity. Consequently, for the present study, we selected gentamicin for analysis of its effects on the proliferation and differentiation capabilities of MSCs under culture conditions. As shown in Fig. 1 , gentamicin did not affect MSC proliferation at a concentration below 100 µg/ml. However, a concentration of 50 µg/ml did inhibit osteoblastic differentiation of the MSCs (Figs. 4 and 5) . In contrast, a concentration of 20 µg/ml well supported osteoblastic/ chondrogenic differentiation and did not exhibit alteration of cell surface antigen expression. The level was sufficient to prevent growth of bacteria, such as staphylococcus aureus and pseudomonas aeruginosa, both of which are known frequent contaminants in tissue culture ( Table 1 ). The concentration is even greater than the MIC of Serratia marcescens, whose value is highest among the MICs listed in Table 1 18 . These results indicate that 20 µg/ml of gentamicin is an appropriate concentration for human MSC cultures because it is sufficient to prevent various kinds of bacterial contamination yet has no inhibitory effects on MSC growth and differentiation capabilities. Based on these results, we are now using human MSC cultures in the presence of 20 µg/ml of gentamicin for bone tissue engineering in clinical situations. To date, we have experienced neither bacterial contamination of cultures nor complications caused by patient infection. For cartilage regeneration, cultured cells from autologous chondrocytes are generally used. However, morbidity is clearly taking a normal patient's cartilaginous portion as the source of chondrocyte culture. In this regard, Wakitani reported that cultured MSCs could be used for cartilage regeneration. In fact, as seen in Fig. 7 , human MSCs have the capability to differentiate into chondrocytes. The important point is that chondrogenic differentiation is not inhibited in the presence of 20 µg/ml of gentamicin. Therefore, we are now using
MSCs from the patient for cartilage regeneration. No complications have been observed after MSC transplantation as is seen in cases of bone regeneration. In summary, cultured human MSCs can be used for hard tissue regeneration. By adding 20 µg/ml of gentamicin to the culture medium, a safe and effective culture can be achieved. MIC: minimum inhibitory concentration (µg/mL).
